Best Willow Alternatives
Willow scores 51.9/100 in our independent evaluation, but it isn't the right fit for everyone. The most common reasons people look elsewhere: reportedly referred by the national advertising division to state attorneys general (dec 2025) over advertising claims — unverified independently this cycle, needs manual confirmation; and service limited to a narrow footprint (reportedly ~12 states), well below most national competitors. Here are the 8 brands that compete with it most directly, ranked by category overlap and overall score.
Read our full Willow review for the complete score breakdown.
The largest publicly traded D2C telehealth platform, offering treatments across hair loss, ED, mental health, skincare, and weight loss.
- ▸Higher overall score (77.5/100 vs 51.9/100)
- ▸Stronger trust & safety score (75 vs 48)
- ▸Better value score (70 vs 52)
Combined men's and women's hormone-health telehealth brand offering TRT, BHRT, GLP-1 weight loss, peptide/longevity add-ons, and sexual-health treatment with no membership or consult fees.
- ▸Higher overall score (74.6/100 vs 51.9/100)
- ▸Stronger trust & safety score (70 vs 48)
- ▸Better value score (78 vs 52)
Pay-per-visit marketplace connecting patients with licensed providers — no subscriptions, transparent per-visit pricing.
- ▸Higher overall score (74/100 vs 51.9/100)
- ▸Stronger trust & safety score (75 vs 48)
- ▸Better value score (80 vs 52)
Async telehealth platform for sexual and reproductive health, prescribing UTI, BV, yeast, herpes, STI, birth control, and menopause treatment at scale with no consult fee.
- ▸Higher overall score (73.6/100 vs 51.9/100)
- ▸Stronger trust & safety score (72 vs 48)
- ▸Better value score (78 vs 52)
Physician-founded telehealth platform offering flat-rate compounded GLP-1 medications with dietitian support, expanding into 15+ specialty care categories.
- ▸Higher overall score (66.8/100 vs 51.9/100)
- ▸Stronger trust & safety score (65 vs 48)
- ▸Better value score (75 vs 52)
GLP-1 telehealth platform with peer-reviewed clinical outcomes data, offering compounded semaglutide and tirzepatide alongside women's hormone therapy across 49 states.
- ▸Higher overall score (57.8/100 vs 51.9/100)
- ▸Stronger trust & safety score (55 vs 48)
- ▸Better value score (70 vs 52)
Hone Health pairs an at-home 50+ biomarker blood panel with physician-directed hormone, weight-loss, and men's/women's health telehealth under a tiered membership model.
- ▸Higher overall score (77.5/100 vs 51.9/100)
- ▸Stronger trust & safety score (78 vs 48)
- ▸Better value score (70 vs 52)
Vertically integrated private telehealth with in-house pharmacy, diagnostics, and an Eli Lilly partnership for branded GLP-1s.
- ▸Higher overall score (77/100 vs 51.9/100)
- ▸Stronger trust & safety score (85 vs 48)
- ▸Better value score (65 vs 52)
Not sure which fits? Answer a few questions and we'll match you.
Take the Match Quiz